(Q37273380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

review article

1 reference

title

First renin inhibitor, aliskiren, for the treatment of hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Darren M Triller

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Samuel D Evang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Bong Kyu Yoo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

18 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Pharmacy

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

741-749

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

14 January 2020

cites work

1 reference

12 December 2020

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study

1 reference

12 December 2020

Aliskiren: a review of its use in the management of hypertension

1 reference

12 December 2020

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

1 reference

12 December 2020

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan

1 reference

12 December 2020

Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives

1 reference

12 December 2020

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

12 December 2020

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

12 December 2020

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren

1 reference

12 December 2020

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

1 reference

12 December 2020

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

1 reference

12 December 2020

Aliskiren: a renin inhibitor offering a new approach for the treatment of hypertension

1 reference

12 December 2020

The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.

1 reference

12 December 2020

Aliskiren for renin inhibition: a new class of antihypertensives

1 reference

12 December 2020

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

1 reference

12 December 2020

Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension

1 reference

12 December 2020

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

12 December 2020

10.1007/S11096-008-9252-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802783%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference